These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10071133)

  • 21. Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy.
    Kantarjian HM; Talpaz M; Hester J; Feldman E; Korbling M; Liang J; Rios MB; Smith TL; Calvert L; Deisseroth AB
    J Clin Oncol; 1995 Mar; 13(3):553-9. PubMed ID: 7884415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic response.
    Martinelli G; Montefusco V; Amabile M; Lemoli RM; Terragna C; Testoni N; Ottaviani E; Rosti G; de Vivo A; Rizzi S; Russo D; Bregoli M; Tura S
    Leuk Lymphoma; 2000 Sep; 39(1-2):113-20. PubMed ID: 10975389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobilization of Ph chromosome-negative peripheral blood stem cells in chronic myeloid leukaemia patients with imatinib mesylate-induced complete cytogenetic remission.
    Drummond MW; Marin D; Clark RE; Byrne JL; Holyoake TL; Lennard A;
    Br J Haematol; 2003 Nov; 123(3):479-83. PubMed ID: 14617010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factor.
    Kantarjian HM; Talpaz M; Kontoyiannis D; Gutterman J; Keating MJ; Estey EH; O'Brien S; Rios MB; Beran M; Deisseroth A
    J Clin Oncol; 1992 Mar; 10(3):398-405. PubMed ID: 1740679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purine nucleoside analogues in the treatment of myleoid leukemias.
    Robak T
    Leuk Lymphoma; 2003 Mar; 44(3):391-409. PubMed ID: 12688309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests.
    Janssen JJ; van Rijn RS; van der Holt B; Schuurhuis GJ; Vellenga E; Verhoef GE; Ossenkoppele GJ; van den Berg E; Hagemeijer A; Släter R; Nieuwint AW; Cornelissen JJ
    Bone Marrow Transplant; 2000 Jun; 25(11):1147-55. PubMed ID: 10849527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Filgrastim-induced stem cell mobilization in chronic myeloid leukaemia patients during imatinib therapy: safety, feasibility and evidence for an efficient in vivo purging.
    Kreuzer KA; Klühs C; Baskaynak G; Movassaghi K; Dörken B; le Coutre P
    Br J Haematol; 2004 Jan; 124(2):195-9. PubMed ID: 14687030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Boqué C; Grañena A
    Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of protocol HX-97 on mobilization, collection and hematopoietic reconstitution of peripheral blood stem cells transplantation].
    Liu T; Jia Y; Lu Z; Qin L; Xu C; Wu J; Deng C
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):428-30. PubMed ID: 11387960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.
    Carella AM; Cunningham I; Lerma E; Dejana A; Benvenuto F; Podestà M; Celesti L; Chimirri F; Abote M; Vassallo F; Figari O; Parodi C; Sessarego M; Valbonesi M; Carlier P; Prencipe E; Gatti AM; van den Berg D; Hoffman R; Frassoni F
    J Clin Oncol; 1997 Apr; 15(4):1575-82. PubMed ID: 9193355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor given in addition to interferon-alpha to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia.
    Archimbaud E; Michallet M; Philip I; Charrin C; Clapisson G; Belhabri A; Guilhot F; Stryckmans P; Adeleine P; Fière D
    Br J Haematol; 1997 Dec; 99(3):678-84. PubMed ID: 9401084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products.
    Gordon MK; Sher D; Karrison T; Kebriaei P; Chuang K; Zhang Y; McDonnell D; Artz A; Godley L; Odenike O; Rich E; Michaelis L; Thirman MJ; Wickrema A; van Besien K; Larson RA; Stock W
    Leuk Lymphoma; 2008 Mar; 49(3):531-7. PubMed ID: 18297531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.
    Thomas X; Suciu S; Rio B; Leone G; Broccia G; Fillet G; Jehn U; Feremans W; Meloni G; Vignetti M; de Witte T; Amadori S
    Haematologica; 2007 Mar; 92(3):389-96. PubMed ID: 17339189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy.
    Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L
    Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048
    [No Abstract]   [Full Text] [Related]  

  • 36. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied.
    Fischer T; Neubauer A; Mohm J; Huhn D; Busemann C; Link H; Arseniev L; Büssing B; Novotny J; Ganser A; Duyster J; Bunjes D; Westermeier T; Flohr T; Desprès D; Gamm H; Decker J; Derigs G; Aulitzky W; Huber C
    Ann Hematol; 1998; 77(1-2):21-6. PubMed ID: 9760148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.
    Koç ON; Gerson SL; Cooper BW; Laughlin M; Meyerson H; Kutteh L; Fox RM; Szekely EM; Tainer N; Lazarus HM
    J Clin Oncol; 2000 May; 18(9):1824-30. PubMed ID: 10784622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mobilization and transplantation of Philadelphia chromosome-negative peripheral blood progenitor cells in patients with CML.
    Waller CF; Heinzinger M; Rosenstiel A; Lange W
    Br J Haematol; 1998 Oct; 103(1):227-34. PubMed ID: 9792314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
    Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.